Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 3.5B | 3.4B | 3.6B | 3.7B |
Cost of revenue | 3.0B | 3.0B | 3.0B | 3.1B |
Gross profit | 465M | 362M | 571M | 640M |
Operating expense | ||||
Research & development | 90M | 118M | 85M | 98M |
Selling general and admin | 477M | 482M | 445M | 474M |
Other operating expenses | 14M | 8M | 12M | 19M |
Operating income | -97M | -191M | 76M | 81M |
Non operating interest income | ||||
Income | 9M | 13M | 14M | 13M |
Expense | 35M | 48M | 39M | 33M |
Other income expense | — | — | — | — |
Pretax income | -141M | -162M | 52M | 52M |
Tax provision | 20M | 30M | 21M | 126M |
Net income | -161M | -192M | 31M | -74M |
Basic EPS | -0.9 | — | 0.2 | -0.4 |
Diluted EPS | -0.9 | — | 0.2 | -0.4 |
Basic average shares | 188.7M | — | 188.7M | 189.6M |
Diluted average shares | 188.7M | — | 188.7M | 189.6M |
EBITDA | 128M | 208M | 302M | 324M |
Net income from continuing op. | -161M | -192M | 31M | -74M |
Minority interests | 1M | 0 | 2M | 2M |
Preferred stock dividends | 0 | 0 | 0 | 0 |